U.S. futures are pointing to a mixed open this morning after a setback for Johnson & Johnson's coronavirus vaccine trial. Investors are also monitoring any movement on stimulus negotiations. For more on the markets, we spoke to Barbara Doran, CEO & Chief Investment Officer at BD8 Capital Partners.